Cart is empty Past public ire over high drug prices has recently taken a back seat to a more insidious problem—no drugs at any price.
DPP debate on revised powers rages
By Nation Reporter
THE National Prosecution Authority (Amendment) Bill has continued to stir emotions in Parliament as Minister of Justice Mulambe Haimbe kept interjecting opposition members debating the bill through points of order.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Bodybuilding supplement may help stave off progression of Alzheimer’s
RUSH researchers recently discovered that a muscle-building supplement called beta-hydroxy beta-methylbutyrate, also called HMB, may help protect memory, reduce plaques and ultimately help prevent the progression of Alzheimer’s disease. Results from the study were published in Cell Reports.
Promising new drug could manage high blood pressure for up to six months with a single injection
A new drug could help lower persistent high blood pressure for up to six months following a single injection, a study suggests. If successful, the drug—zilebesiran—would provide a more convenient method for the management of high blood pressure, which is routinely treated through daily tablets. The work is published in the New England Journal of Medicine.
Using prebiotics to help treat Parkinson’s disease
Constipation can be caused by many factors, not all of them serious. But it could be a sign of Parkinson’s disease. A new study from RUSH neurologist Deborah Hall, MD, looks into how the bowel and the brain are linked.
Global diabetes cases on pace to soar to 1.3 billion people in the next 3 decades, new study finds
The number of people living with diabetes worldwide is on pace to more than double in the next three decades, for a total of 1.3 billion people by 2050. That is one of the key findings from the study on the global burden of diabetes recently published in The Lancet.
Q&A: Study provides new insights into type 2 diabetes
New insights into the underlying mechanisms of type 2 diabetes and novel potential therapeutic targets for the disease were revealed in a recent study by a team of Texas A&M AgriLife Research scientists in the Department of Nutrition at Texas A&M’s College of Agriculture and Life Sciences.
Adaptation of booster vaccines against omicron variants important for COVID-19, study shows
Booster vaccinations (third and fourth vaccinations) of COVID-19 mRNA vaccines that are not adapted to omicron variants do lead to higher blood levels of neutralizing antibodies against the omicron subvariants. However, these antibody titers drop significantly six months after the third or fourth vaccination. The fourth vaccination also had no effect on the breadth of the immune response against different virus variants.
Marijuana use linked to epigenetic changes
Recent and long-term marijuana use is linked to changes in the human epigenome, a new Northwestern Medicine study published in Molecular Psychiatry has found.
MIND diet trial finds no significant cognitive improvements or changes in brain morphology
Research into the effects of the MIND diet led by the Rush Alzheimer’s Disease Center, Chicago, has found no significant improvement after three years compared to a control diet group with mild caloric restriction. In a paper, “Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons,” published in the New England Journal of Medicine, the researchers detail the outcome of a study investigating if the MIND diet could improve cognition and brain health as potential protection against cognitive decline and Alzheimer’s disease.